Renascience Inc.

4889 TSE Pharmaceuticals Pharmaceutical
TSE Growth
¥1,150.00
-5.35%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Low debt: debt-to-equity of 0.05.
  • Current assets comfortably cover current liabilities (current ratio 19.4).

!Watch-points

  • Return on equity is on the lower side at -9.1%.
  • Return on capital employed is on the lower side at -10.7%.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreDistress zone
0.35

In Altman’s study, scores in this range were associated with a higher incidence of financial distress.

Computed without the market-value term.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap¥158億
Current Price¥ 1,150.00
High / Low¥ 2,342.00 / 1,101.00
Stock P/E-49.17
Book Value¥ 240.26
Dividend Yield0%
ROCE-10.74%
ROE-9.10%
Debt to Equity0.05
Current Ratio19.40
P/B Ratio4.889955
EPS¥ -23.39
Educational data only. Not a recommendation to buy, sell or hold any security.